Biocryst Pharmaceuticals (BCRX) Payables (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Payables came in at $11.0 million in Q1 2026, up 9.05% YoY from $10.0 million in Q1 2025, and down 30.76% on a QoQ basis from $15.8 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Payables (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of Payables data on file, last reported at $11.0 million in Q1 2026.
- Quarterly Payables rose 9.05% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (up 9.05% YoY) and the FY2025 annual result came in at $15.8 million, up 35.92% from the prior year.
- Payables fell to $11.0 million in Q1 2026, from $15.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $20.9 million in Q4 2023 to a low of $5.6 million in Q3 2025.
- A 5-year average of $11.5 million and a median of $11.6 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables slumped 82.65% — and 2024, when it jumped 90.44%.
- Tracing BCRX's Payables over 5 years: stood at $14.4 million in 2022, then soared by 45.53% to $20.9 million in 2023, then plunged by 44.27% to $11.6 million in 2024, then jumped by 35.92% to $15.8 million in 2025, then tumbled by 30.76% to $11.0 million in 2026.
- The last three Payables figures came in at $11.0 million (Q1 2026), $15.8 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 10.96 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Mar 31, 2025 | 10.05 Mn |
| Dec 31, 2024 | 11.64 Mn |
| Sep 30, 2024 | 13.48 Mn |
| Jun 30, 2024 | 7.79 Mn |
| Mar 31, 2024 | 11.91 Mn |
| Dec 31, 2023 | 20.89 Mn |
| Sep 30, 2023 | 10.57 Mn |
| Jun 30, 2023 | 13.89 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 14.36 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 13.88 Mn |
| Dec 31, 2021 | 27.81 Mn |
| Sep 30, 2021 | 49.69 Mn |